CDH3 and cancer: We have recently demonstrated that P-cadherin is able to interfere with the tumour suppressive function of E-cadherin in breast carcinomas and in cell culture, promoting cancer cell invasion by disrupting the interaction between E-cadherin and both p120ctn and βctn [79].